Blood Screening Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 REPORT DESCRIPTION Blood Screening Market – Overview Increasing demand for NAT over ELISA (enzyme-linked immunosorbent assay) test due to high sensitivity and specificity for viral nucleic acid is boosting growth of the blood screening market. For instance, in 2018, Grifols received approval from the U.S. Food & Drug Administration (FDA) for two blood screening assays- Procleix Ultrio Elite and Procleix WNV. Both assays run on the fully automated NAT blood screening platform: Procleix Panther system. The Procleix Panther system with these assays helps blood centers to efficiently screen for infectious diseases and eliminates the need of batch processing. Increasing number of blood donations campaigns by the government, blood donor agencies, and NGO’s are expected to propel growth of the blood screening market. For instance, according to the WHO reported data in June 2017, around 112.5 million blood donations are collected globally and around half of these are collected in high-income countries, highlighting 19% of the world’s population. Moreover, increase in initiatives by the government to create awareness among the people regarding safety of the donated blood is expected to drive growth of the market. For instance, in 2014, World Health Organization (WHO) recommended to establish a national blood system with well-organized and coordinated blood transfusion services, effective evidence-based and ethical national blood policies, and legislation and regulation that can provide sufficient and timely supplies of safe blood and blood products to meet the transfusion needs of all patients. REPORT DESCRIPTION Blood Screening Market Taxonomy: By Technology: Nucleic acid amplification technology (NAT) ELISA Immunoassays (IAs) Next-Generation Sequencing (NGS) Western Blotting By Product Type Reagents & Kits Instruments Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2409 REPORT DESCRIPTION Blood Screening Market – Key Players Grifols F. Hoffmann-La Roche Abbott Laboratories Biomérieux Bio-Rad Laboratories, Inc Siemens Healthineers (A Subsidiary of Siemens AG) Ortho Clinical Diagnostics, Inc Thermo Fisher Scientific, Inc Beckman Coulter (A Subsidiary of Danaher Corporation) Becton Dickinson and Company Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/blood-screening-market-2409 ABOUT COHERENT MARKET INSIGHTS Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES CUSTOMIZED RESEARCH CONSULT STUDIES SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS        Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies ABOUT US KEY STATS RESEARCH SOLUTIONS FEASIBILITY STUDIES GLOBAL REPORTS 100+ Insights Published Per Year 150+ Consulting Projects Till Date 125+ Clients Worldwide Per Year 110+ COUNTRY ANALYSIS CONSULT PROJECTS SURVEY RESEARCH EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique —we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Increasing demand for NAT over ELISA (enzyme-linked immunosorbent assay) test due to high sensitivity and specificity for viral nucleic acid is boosting growth of the blood screening market.